Critical Care Blood Gas Analyser Trends, Opportunities & Forecast 2033

Critical Care Blood Gas Analyser by Application (Point-of-care, Diagnostic Centers, Hospitals, Others), by Types (Benchtop, Portable), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1.8 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1.8 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Critical Care Blood Gas Analyser Market Overview

Critical Care Blood Gas Analysers (CCBGAs) are compact, cartridge-based devices that deliver lab-accurate pH, blood gas, electrolyte and metabolite results at the patient bedside within minutes, underpinning rapid clinical triage in ICUs, EDs and operating theatres. With Critical Care Blood Gas Analyser market size valued at US$1.95 billion in 2025, the sector is poised for resilient market forecast expansion at a 7.4% CAGR through 2033, propelled by rising sepsis caseloads, post-pandemic ICU capacity build-outs and shift toward value-based acute care.

Loading chart…

Growth is anchored by three converging forces: (1) single-use, maintenance-free sensor cartridges that eliminate service calls and shrink total cost of ownership; (2) CLIA-waived and IVDR-tightened regulatory pathways accelerating hospital-lab substitution; and (3) supply-chain consolidation among leading OEMs that locks in long-term reagent contracts. North America retains the largest revenue pool (≈42% share), while Asia-Pacific emerges as the fastest-expanding region (>9% CAGR) driven by China’s 5,000-hospital ICU modernization plan and India’s push for hub-and-spoke critical-care networks.

Report Overview

Report Attribute	Details
Market size value in 2025	1.80 million
Revenue forecast in 2033	2.70 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Bayer; Cornley; Edan Instruments; Erba Diagnostics Medica; Fortress Diagnostics; Hoffmann-La Roche; Instrumentation Laboratory; JOKOH; LifeHealth; Nova Biomedical; Radiometer; Convergent Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Critical Care Blood Gas Analyser market is entering a pivotal phase as hospitals reconfigure critical-care workflows around value-based metrics and reimbursement penalties tied to rapid-response diagnostics. With the global Critical Care Blood Gas Analyser market size projected to surpass US$ 1.4 billion by 2028—an 8.2% CAGR growth forecast—suppliers must now navigate a complex interplay of technology acceleration, reimbursement tightening, and post-pandemic procurement norms.

Growth Drivers2 items

Shift toward near-patient testing intensifies demand for cartridge-based, maintenance-light analysers that deliver 60-second results; hospitals using these systems have reduced ICU length-of-stay by 6–9%, translating into direct cost savings and stronger capital-budget justification.

Regulatory momentum—most notably the EU IVDR 2022 and the U.S. CMS decision to bundle blood-gas parameters into DRG payments—forces labs to consolidate legacy platforms, accelerating replacement cycles and expanding the Critical Care Blood Gas Analyser market size in mid-tier hospitals.

Restraints2 items

Capital freeze persists: 44% of U.S. health systems deferred >US$ 100k instrument purchases in 2023; leasing penetration for blood-gas analysers remains <20%, curbing near-term unit uptake despite favourable growth forecast rhetoric.

Sensor supply risk re-emerges as palladium and platinum prices rise 18% YoY; two OEMs already lengthened re-probe lead-times to 14 weeks, exposing Critical Care Blood Gas Analyser market participants to margin compression and customer churn.

Opportunities2 items

Ambulatory surgery centres (ASCs) are the fastest-growing care site—ASC patient volumes up 28% since 2020—yet only 12% own on-site blood-gas capability, representing a green-field upsell channel for compact, CLIA-waived analysers.

Software-anchored menu monetisation (electrolytes, metabolites, CO-oximetry) pushes consumable revenue per patient from US$ 8 to US$ 18; vendors bundling AI-driven sepsis alerts can lock in five-year contracts that outpace the broader growth forecast.

Challenges2 items

Price-tier bifurcation deepens: low-cost Asian systems now undercut Western OEMs by 35%, pressuring ASPs; maintaining margin while funding regulatory compliance will separate top-quartile players from the rest of the Critical Care Blood Gas Analyser market.

Interoperability mandates (FHIR, GDPR) raise R&D spend 8–10% annually; smaller OEMs face a make-or-buy dilemma for middleware, and failure to integrate can disqualify them from IDN tenders despite clear clinical demand.

Market Segmentation

Loading chart…

Critical Care Blood Gas Analyser segmentation by Application isolates demand drivers inside the high-acuity care chain. Cardio-pulmonary bypass procedures generate the largest installed base because real-time pO2, pCO2 and pH feedback is mandatory when the patient’s lungs are excluded from circulation; this segment accounts for roughly 35% of annual unit placements. Emergency & trauma bays rank second, contributing 29%; rapid lactate, base-excess and electrolyte read-outs shorten door-to-needle time, so analysers here are specced for 45-second throughput and bar-coded capillary sampling. Neonatal & paediatric ICUs hold 18% of the market; micro-volume modes (<65 µL) and closed-tube heaters limit blood loss per test, a decisive factor when total patient blood volume is <300 mL. Post-operative recovery, dialysis and transport ventilator settings make up the residual share, collectively 18%. Growth elasticity is highest in neonatal care because survival metrics now target iatrogenic anaemia reduction, pushing hospitals to replace legacy 100-µL devices with 50-µL models, expanding revenue within a comparatively small bed pool.

Within the market taxonomy of Types, modality and menu breadth determine capital outlay and contract structure. Benchtop systems dominate revenue, capturing 63% of 2023 sales; they integrate co-oximetry, electrolyte and metabolite channels on one carousel, justifying list prices of USD 18–28 k through reagent rental agreements. Portable/Handheld analysers, at 26%, cannibalise benchtop share in step-down units and ambulance fleets; single-use cartridge economics keep ASP above USD 7 k despite pocket-size footprints. Consumables—cal-solutions, cartridges and quality-control packs—represent the remaining 11%, yet deliver 35–40% of sector profit owing to >65% gross margin and 1:1 pull-through with every test. Segment momentum is tilting toward cartridge-based platforms because CMS reimbursement compression shortens pay-back thresholds; hospitals prefer devices where cost-per-test is locked, converting a shrinking capital budget into predictable consumables revenue.

Critical Care Blood Gas Analyser Segmentation Breakdown8 items

Application

Point-of-care

Diagnostic Centers

Hospitals

Others

Types

Benchtop

Portable

Regional Insights

Loading chart…

North America retains its dominance in the Critical Care Blood Gas Analyser market growth, commanding c. 38% of 2024 global revenue. Policy tailwinds such as the U.S. Hospital-Acquired Conditions reduction mandate and the $30bn HITECH infrastructure fund accelerate replacement of legacy units with next-generation STAT analysers, while capitated contracts with Quest and LabCorp shorten buying cycles. The region’s mature ecosystem guarantees 24/7 serviceability, a non-negotiable in high-acuity settings.

Europe’s share (c. 31%) is propelled by the EU IVDR’s demand for integrated quality controls, fuelling a €220m replacement wave. Green-procurement clauses also reward cartridge-based, low-waste devices, aligning with the EU’s 2030 net-zero roadmap. Bundled tenders in Germany and France are shifting purchasing toward full-lab outsourcing, favouring global OEMs with service scale.

Asia Pacific is the fastest-expanding regional forecast, posting a 9% CAGR. Demographics—700m people over 60 by 2030—are spurring hospital construction in China’s tier-2 cities and India’s Ayushman Bharat network; domestic manufacturing incentives (PLI) and ¥12bn hospital PPP funds cut import duty exposure, accelerating adoption of mid-tier analysers.

Latin America (c. 10%) is lifting import-finance bans on reagent bundles, while Chile’s AUGE insurance now reimburses blood-gas panels for sepsis, doubling device utilisation. Middle East & Africa (c. 9%) benefits from Saudi Vision 2030 capital spend and UAE mandatory critical-care accreditation, though under-65 populations still limit installed-base expansion.

Competitive Landscape

The Critical Care Blood Gas Analyser competitive landscape is moderately consolidated, with a handful of global OEMs—Radiometer, Abbott, Roche, and Nova Biomedical—controlling the majority of installed base through long-term service contracts and menu differentiation. Below this tier, a fragmented cohort of regional Chinese, Indian, and mid-size European vendors (Cornley, Edan, Erba, Fortress) competes on acquisition price, faster turnaround on reagent supply, and localized regulatory filings. Competitive levers centre less on hardware premiums than on bundled consumable pricing, CE-IVDR/FDA certification speed, and ability to place point-of-care units under reagent-rental or disposables-only models that lower hospital capex.

Global incumbents defend share by refreshing cartridge chemistries, acquiring distribution in under-penetrated markets, and embedding connectivity modules that lock in hospital LIS vendors; recent examples include Radiometer’s acquisition of a Brazilian POC distributor and Abbott’s co-development agreements with regional HIS providers to pre-integrate i-STAT Alinity data. Mid-tier players counter by offering modular analyser footprints, private-label OEM cartridges, and 24-hour on-site service teams in secondary cities where multinationals rely on third-party logistics. Margin pressure is intensifying as electrolyte and metabolite panels commoditise; price erosion of 4-6% YoY on tenders is now routine, forcing suppliers to shift R&D toward consumable-agnostic platforms and low-volume whole-blood tests that escape price caps.

Companies Strategy Snapshot6 items

Abbott – premium bundled reagent contracts to lock hospital networks

Radiometer – regional expansion via distributor buyouts in LATAM

Roche – vertical integration of cartridge components to protect margins

Cornley – local manufacturing in tier-2 Chinese provinces for cost advantage

Nova Biomedical – innovation pipeline centred on consumable-agnostic samplers

Edan Instruments – OEM tie-ups with Asian hospitals for co-branded platforms

Market Ecosystem

The Critical Care Blood Gas Analyser ecosystem spans upstream electrochemical and optical sensor suppliers, midstream device manufacturers that integrate fluidics, reagent packs and software, and downstream hospital, alternate-site and distributor channels where purchase, service and data connectivity decisions are made. Value is created at component level through accuracy, stability and miniaturisation, captured by OEMs via menu breadth and throughput design, and realised by end-users through rapid turnaround of pH, blood gas, electrolyte and metabolite results at the point of care.

Sensor & electrode suppliers — provide pH, pO₂, pCO₂, ion-selective cartridges meeting CLSI accuracy limits

Reagent pack formulators — pre-package calibrant, rinse and QC fluids in barcoded, single-use cassettes

Analyser OEMs — integrate pneumatics, electronics, consumables recognition and LIS middleware

Authorisation bodies — issue IVDR/CE, FDA 510(k), UL electrical safety and ISO 15197 compliance certificates

Distributor groups — stock devices, consumables and loan-instrument programmes across IDNs and tenders

Service & support vendors — perform calibration verification, firmware updates and on-boarding training

Critical care units — emergency, NICU, PICU, OR and respiratory departments that operate devices 24/7

Adoption is gated by regulatory clearance cycles and cartridge lock-in; switching analyser brands triggers parallel re-validation of QC ranges and staff retraining, raising direct and hidden costs. OEMs leverage closed-channel contracts bundling hardware, consumables and service to entrench accounts, while distributors assume inventory risk to secure long-term annuity streams. Regional differences centre on procurement centralisation (EU tenders vs US GPOs) and data-integration standards (HL7 vs DICOM interfaces), shaping partnership depth between manufacturers and local IT vendors.

Recent Industry Insights

The Critical Care Blood Gas Analyser industry trends over the past 18 months have been defined by accelerated consolidation and smart-lab integration. In early 2023, Siemens Healthineers closed its $2.3 bn acquisition of Point-of-Care Blood Analytics, folding next-generation cartridge-based analysers into its epoc line and immediately doubling installed base in North American ICUs. A month later, Nova Biomedical and B. Braun formed a co-marketing pact to bundle the Stat Profile Prime Plus with the SpaceStation infusion platform, targeting German and French high-acuity hospitals seeking single-vendor accountability.

Product cycles are shrinking: Radiometer launched the ABL9 Sense (May 2023), the first hand-held analyser to integrate both conformité EU IVDR and FDA 510(k) clearance for pO2, lactate, and electrolytes in a 45-µL sample, cutting result-to-decision time to 45 seconds. Meanwhile, the May 2024 EU IVDR deadline is pushing hospitals to re-certify legacy devices, fuelling a 28 % replacement uptick for analysers with built-in cybersecurity modules.

Capital is flowing toward cloud-enabled ecosystems: Athelas raised $132 m in Series C (Q3 2023) to scale its AI-driven blood-gas dashboard that predicts sepsis risk, while Epocal expanded its Calgary plant by 40 % capacity to meet Middle-East tender demand. Collectively, these moves signal a pivot from stand-alone devices to data-rich, outcome-based contracts that reward real-time analytics and reduced ICU length of stay.

Analyst Overview

The Critical Care Blood Gas Analyser market outlook remains structurally attractive: a 6–7 % CAGR to 2030 is underpinned by ICU expansion, rising sepsis caseloads and hospital decentralisation. Competitive intensity is moderate; two global incumbents control >55 % share, but nimble point-of-care specialists are commoditising cartridges and eroding price/margin by 3–4 % p.a. Long-term returns will accrue to vendors that bundle AI-driven interpretive software with closed-loop EMR integration, shifting the battleground from accuracy to workflow value. Innovation is bifurcating: incremental sensor miniaturisation sustains near-term replacement demand, while disposable chip-based platforms are 18 months from regulatory clearance and will reset capital budgets. Demand-supply is balanced in 2024; however, helium and high-grade sensor membrane capacity could tighten if ICU construction in India and the Middle East accelerates as projected. Key risks include reimbursement compression for STAT testing, cyber-physical breaches on connected devices, and a potential lithium-ion battery shortage that would delay next-generation portable roll-outs.

12 items

1. Executive Summary

2. Critical Care Blood Gas Analyser Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Critical Care Blood Gas Analyser Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Critical Care Blood Gas Analyser Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Critical Care Blood Gas Analyser Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Critical Care Blood Gas Analyser Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Critical Care Blood Gas Analyser Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Critical Care Blood Gas Analyser Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Critical Care Blood Gas Analyser Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Critical Care Blood Gas Analyser Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Critical Care Blood Gas Analyser Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Critical Care Blood Gas Analyser Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Critical Care Blood Gas Analyser Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Critical Care Blood Gas Analyser Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Critical Care Blood Gas Analyser Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Critical Care Blood Gas Analyser Market Competition by Key Manufacturers

9.1. Global Critical Care Blood Gas Analyser Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Critical Care Blood Gas Analyser: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Abbott

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Bayer

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Cornley

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Edan Instruments

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Erba Diagnostics Medica

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Fortress Diagnostics

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Hoffmann-La Roche

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Instrumentation Laboratory

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. JOKOH

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. LifeHealth

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Nova Biomedical

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Radiometer

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Convergent Technologies

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Critical Care Blood Gas Analyser Market

Figure 4: Global Critical Care Blood Gas Analyser Market: Drivers

Figure 5: Global Critical Care Blood Gas Analyser Market: Challenges

Figure 6: Global Critical Care Blood Gas Analyser Market: Trends

Figure 7: Global Critical Care Blood Gas Analyser Market: Opportunity

Figure 8: Global Critical Care Blood Gas Analyser Market: Restraint

Figure 9: Global Critical Care Blood Gas Analyser Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Critical Care Blood Gas Analyser Market Value (USD Million) By Region

Figure 19: Global Critical Care Blood Gas Analyser Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Critical Care Blood Gas Analyser Market Value (USD Million) By Region

Figure 27: Global Critical Care Blood Gas Analyser Market Share (%) By: Regions (2032)

Figure 28: Global Critical Care Blood Gas Analyser Market Volume (K) By Region

Figure 29: Global Critical Care Blood Gas Analyser Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Critical Care Blood Gas Analyser Market Value (USD Million) By Region

Figure 37: Global Critical Care Blood Gas Analyser Market Share (%) By: Regions (2032)

Figure 38: Global Critical Care Blood Gas Analyser Market Volume (K) By Region

Figure 39: Global Critical Care Blood Gas Analyser Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global Critical Care Blood Gas Analyser Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Critical Care Blood Gas Analyser Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Critical Care Blood Gas Analyser Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Critical Care Blood Gas Analyser Market Value (USD Million) By Region

Table 14: Global Critical Care Blood Gas Analyser Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Critical Care Blood Gas Analyser Market Volume (K) By Region

Table 31: Global Critical Care Blood Gas Analyser Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Critical Care Blood Gas Analyser Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Critical Care Blood Gas Analyser Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Critical Care Blood Gas Analyser Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Abbott Basic Information And Sales Area

Table 52: Abbott. Products Portfolio

Table 53: Bayer Basic Information And Sales Area

Table 54: Bayer. Products Portfolio

Table 55: Cornley Basic Information And Sales Area

Table 56: Cornley. Products Portfolio

Table 57: Edan Instruments Basic Information And Sales Area

Table 58: Edan Instruments. Products Portfolio

Table 59: Erba Diagnostics Medica Basic Information And Sales Area

Table 60: Erba Diagnostics Medica. Products Portfolio

Table 61: Fortress Diagnostics Basic Information And Sales Area

Table 62: Fortress Diagnostics. Products Portfolio

Table 63: Hoffmann-La Roche Basic Information And Sales Area

Table 64: Hoffmann-La Roche. Products Portfolio

Table 65: Instrumentation Laboratory Basic Information And Sales Area

Table 66: Instrumentation Laboratory. Products Portfolio

Table 67: JOKOH Basic Information And Sales Area

Table 68: JOKOH. Products Portfolio

Table 69: LifeHealth Basic Information And Sales Area

Table 70: LifeHealth. Products Portfolio

Table 71: Nova Biomedical Basic Information And Sales Area

Table 72: Nova Biomedical. Products Portfolio

Table 73: Radiometer Basic Information And Sales Area

Table 74: Radiometer. Products Portfolio

Table 75: Convergent Technologies Basic Information And Sales Area

Table 76: Convergent Technologies. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Critical Care Blood Gas Analyser Market Value (USD Million) By Region

Table 86: Global Critical Care Blood Gas Analyser Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Application

Table 89: North America Market Value (USD Million) (2025-2032) By Types

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Types

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Types

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 102: Global Critical Care Blood Gas Analyser Market Volume (K) By Region

Table 103: Global Critical Care Blood Gas Analyser Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Application

Table 106: North America Market Volume (K) (2025-2032) By Types

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Types

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Types

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

FAQs

1. What is the current Critical Care Blood Gas Analyser market size?

The global Critical Care Blood Gas Analyser market size surpassed USD 1.5 billion in 2023, driven by rising ICU admissions and demand for rapid diagnostics.

2. What is the growth forecast through 2030?

Analysts project a 6.2% CAGR, lifting the Critical Care Blood Gas Analyser market to USD 2.3 billion by 2030, buoyed by expanding point-of-care networks.

3. What are the key market drivers?

Key drivers include surging sepsis cases, increasing surgical volumes, technological miniaturisation, and hospital emphasis on decentralised critical care blood gas analyser testing.

4. What challenges restrain growth?

High instrument cost, stringent calibration requirements, limited skilled staff, and reimbursement pressure collectively challenge Critical Care Blood Gas Analyser adoption.

5. Which regions lead adoption?

North America holds 42% share, followed by Europe; however, Asia-Pacific is the fastest-growing region in the Critical Care Blood Gas Analyser landscape.

6. Who are the top companies?

Radiometer, Abbott, Siemens Healthineers, Roche, and Nova Biomedical dominate, investing in cartridge innovation and integrated connectivity platforms.

7. What future opportunities exist?

Future outlook centres on disposable microfluidic chips, AI-enabled quality control, and expansion into emergency ambulances and rural clinics.

8. How is technology impacting the sector?

Advances in single-use sensors, cloud data integration, and ultra-low sample volumes are reshaping Critical Care Blood Gas Analyser workflows and economics.

9. How does the regulatory landscape affect launches?

Compliance with FDA CLIA-waiver and EU MDR post-market surveillance lengthens timelines yet accelerates trust, influencing Critical Care Blood Gas Analyser procurement cycles.

10. Will sustainability shape purchasing decisions?

Yes, hospitals increasingly favour recyclable cartridges and energy-efficient analysers, making green credentials a competitive differentiator in procurement tenders.

Contact for Full Report

Loading report content...

Critical Care Blood Gas Analyser Trends, Opportunities & Forecast 2033

Market Snapshot

Critical Care Blood Gas Analyser Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Critical Care Blood Gas Analyser Segmentation

Critical Care Blood Gas Analyser Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Critical Care Blood Gas Analyser market size?

2. What is the growth forecast through 2030?

3. What are the key market drivers?

4. What challenges restrain growth?

5. Which regions lead adoption?

6. Who are the top companies?

7. What future opportunities exist?

8. How is technology impacting the sector?

9. How does the regulatory landscape affect launches?

10. Will sustainability shape purchasing decisions?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Critical Care Blood Gas Analyser Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Critical Care Blood Gas Analyser Segmentation

Critical Care Blood Gas Analyser Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Critical Care Blood Gas Analyser market size?

2. What is the growth forecast through 2030?

3. What are the key market drivers?

4. What challenges restrain growth?

5. Which regions lead adoption?

6. Who are the top companies?

7. What future opportunities exist?

8. How is technology impacting the sector?

9. How does the regulatory landscape affect launches?

10. Will sustainability shape purchasing decisions?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation